- VeteransReduces or eliminates out-of-pocket costs for veterans seeking contraceptives at VA facilities.
- Potential benefitIncreases parity between VA benefits and private insurance preventive contraceptive coverage requirements.
- VeteransMay increase contraceptive uptake and continuity of care among veteran patients.
Equal Access to Contraception for Veterans Act
Referred to the Subcommittee on Health.
This bill amends 38 U.S.C. 1722A(a)(2) to limit copayments for contraceptives furnished by the Department of Veterans Affairs. It bars charging more than the Secretary's cost for contraceptive medications and prohibits any cost-sharing for contraceptive items that private insurers must cover without cost-sharing under 42 U.S.C. 300gg–13(a)(4).
Progressives emphasize access and equity benefits for veterans
Relative to its intended legislative type, this bill is a narrowly focused statutory amendment that clearly states its objective and integrates with existing law, but it leaves important operational, fiscal, and edge-case details unspecified.
This bill amends 38 U.S.C. 1722A(a)(2) to limit copayments for contraceptives furnished by the Department of Veterans Affairs.
It bars charging more than the Secretary's cost for contraceptive medications and prohibits any cost-sharing for contraceptive items that private insurers must cover without cost-sharing under 42 U.S.C. 300gg–13(a)(4).
Narrow technical change benefiting veterans improves prospects, but contraception's political salience and absent implementation detail add uncertainty.
Relative to its intended legislative type, this bill is a narrowly focused statutory amendment that clearly states its objective and integrates with existing law, but it leaves important operational, fiscal, and edge-case details unspecified.
Progressives emphasize access and equity benefits for veterans
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Potential burdenReduces copay revenue available to VA medical facilities, potentially affecting internal budgets.
- Potential burdenIncreases VA pharmaceutical and program costs to cover contraceptives without cost-sharing.
- Potential burdenMay create modest administrative burdens to implement new copay rules and tracking systems.
Why the argument around this bill splits.
Progressives emphasize access and equity benefits for veterans
Likely strongly supportive because it expands affordable reproductive health access for veterans and aligns VA practice with ACA preventive coverage rules.
Viewed as reducing financial barriers for veterans, particularly low-income and marginalized groups.
Generally favorable but pragmatic and cautious.
Sees it as a targeted, modest policy improving access, while wanting clarity on cost implications and implementation procedures within the VA.
Likely skeptical or opposed.
Concerns center on expanded benefits and associated federal costs, potential federal overreach into health benefit design, and absence of expressed conscience protections for providers.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Narrow technical change benefiting veterans improves prospects, but contraception's political salience and absent implementation detail add uncertainty.
- No Congressional Budget Office cost estimate provided in text
- How 'cost to the Secretary' will be calculated administratively
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Progressives emphasize access and equity benefits for veterans
Narrow technical change benefiting veterans improves prospects, but contraception's political salience and absent implementation detail add…
Relative to its intended legislative type, this bill is a narrowly focused statutory amendment that clearly states its objective and integrates with existing law, but it leaves important operational, fiscal, and edge-ca…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.